• S&P 500: 1,351.95
  • Change: 0.15%
$1.76 0.03 (+1.73%)
2/9/2012 4:00 PM

Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Current Price $1.76 Mkt Cap $185.99M
Open $0.00 P/E Ratio 0.00
Prev. Close $1.73 Div. (Yield) N/A (N/A)
Daily Range $1.69 - $1.77 Volume 444,067
52-Wk Range $1.25 - $3.45 Avg. Daily Vol. 0

Caps

How do you think ALTH will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

328 Outperform
16 Underperform
 

All-Star Players

76 Outperform
5 Underperform
 

Wall Street

13 Outperform
0 Underperform
 

Top ALTH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tctk1044 (40.72)
Submitted January 22, 2010

Major purchase option for a larger pharmaceutical company. Over the past year this company has stabalized itself significantly. FOLOTYN already has approval through the FDA for use in some cancers, and its market will only grow as the drug gains… More

zzlangerhans (99.31)
Submitted January 14, 2012

Let's face facts. Folotyn just hasn't worked out the way Allos longs hoped it would. I was optimistic and green-thumbed - oops. And now the share price has been creeping up for the last month after bottoming at 1.25. But I'm not seeing Folotyn ever… More

ALTH VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ALTH.

Recs

1
Member Avatar zzlangerhans (99.31) Submitted: 1/13/2012 11:00:38 PM : Underperform Start Price: $1.56 ALTH Score: -7.41

Let's face facts. Folotyn just hasn't worked out the way Allos longs hoped it would. I was optimistic and green-thumbed - oops. And now the share price has been creeping up for the last month after bottoming at 1.25. But I'm not seeing Folotyn ever making Allos cash flow positive, even with European approval and expanded indications. Allos will have to choose between the short-term pain of blowing their cash hoard on a risky new pipeline, and the long-term pain of eroding their cash every quarter as Folotyn revenues fail to keep pace with cost of sales and SGA expenses.

Recs

0
Member Avatar portefeuille (99.84) Submitted: 12/15/2011 9:21:24 PM : Outperform Start Price: $2.14 ALTH Score: -18.86

There are currently 12500 ALTH shares in my "fund" with break-even of around 3.05 USD.
http://caps.fool.com/Blogs/fund-trades/678775.

Recs

0
Member Avatar Haugurafpeningum (98.60) Submitted: 11/8/2011 2:36:40 AM : Outperform Start Price: $1.52 ALTH Score: +9.14

Technical Monthly

Leaderboard

Find the members with the highest scoring picks in ALTH.

Score Leader

kb3itn

kb3itn (78.81) Score: +141.77

The Score Leader is the player with the highest score across all their picks in ALTH.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kb3itn 78.81 3/24/2009 3/22/2010 Underperform 1Y $6.57 -73.23% +68.54% +141.77 0 Comment
anticitradeshort 27.30 4/20/2009 Underperform NS $5.99 -70.62% +59.89% +130.51 0 Comment
WxDog 75.70 7/8/2010 Underperform 5Y $5.50 -68.00% +26.85% +94.85 0 Comment
longtermgrowth09 68.40 12/17/2009 Underperform 5Y $6.00 -70.67% +22.25% +92.92 0 Comment
schwah5 99.26 7/30/2008 Underperform NS $9.07 -80.60% +9.95% +90.54 0 Comment
Ruthie203 45.82 2/15/2008 Underperform 1Y $6.70 -73.73% +4.97% +78.70 1 Comment
qubit17 93.69 12/4/2007 Underperform NS $7.34 -76.02% -3.32% +72.70 0 Comment
twosteptothatyo < 20 11/19/2007 Underperform 1Y $6.39 -72.46% -2.39% +70.07 1 Comment
scfpdoc 42.99 12/28/2007 Underperform 3M $6.35 -72.28% -4.04% +68.24 0 Comment
tamarn2007 97.69 6/18/2007 Underperform 3M $5.69 -69.07% -7.10% +61.97 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackZacks 70.75 11/9/2011 Outperform 3M $1.52 +15.79% +5.14% +10.65 2/6/2012 @ $1.76 1 Comment
TrackZacks 70.75 8/5/2011 Underperform 3M $1.75 +4.57% +0.45% -4.12 8/15/2011 @ $1.83 1 Comment
TrackZacks 70.75 1/12/2011 Underperform 3M $4.21 -27.32% +3.03% +30.34 3/4/2011 @ $3.06 1 Comment
TrackBreanMurray 69.41 9/30/2010 Outperform NS $4.79 -63.26% +17.65% -80.91 0 Comment
TrackJPMorgan < 20 3/4/2010 Outperform NS $6.88 +14.83% +5.66% +9.17 4/30/2010 @ $7.90 0 Comment
trackthinkequity 92.04 11/24/2009 Outperform NS $6.26 -71.88% +21.95% -93.83 0 Comment
TrackLeerinkSwan 87.91 7/14/2009 Outperform NS $7.56 -76.72% +50.48% -127.20 0 Comment
TrackJimCramer 78.02 2/27/2009 Outperform 3W $5.64 -68.79% +86.32% -155.11 0 Comment
TrackWellsFargo 92.44 12/4/2008 Outperform NS $6.01 -70.72% +61.37% -132.09 0 Comment
TrackCitigroup 93.11 6/26/2008 Outperform NS $6.49 -72.88% +6.97% -79.85 0 Comment
TrackMichaelBrus 95.02 2/14/2008 Outperform 1Y $6.75 -73.93% +4.36% -78.29 0 Comment
TrackBofASec 96.89 12/4/2007 Outperform NS $7.26 -75.76% -3.30% -72.45 0 Comment
TrackCollinsStew 66.07 11/8/2007 Outperform NS $5.90 -70.17% -3.91% -66.26 0 Comment
TrackSoros 93.24 9/30/2007 Outperform NS $4.75 -62.95% -7.05% -55.90 1 Comment
TrackRBCCapMkts 93.26 6/20/2007 Outperform NS $5.54 -68.23% -6.80% -61.43 0 Comment
TrackJimCramer 78.02 2/13/2007 Underperform 3W $7.78 -27.51% -48.89% -21.39 2/28/2009 @ $5.64 0 Comment
TrackRodmanRen < 20 12/8/2006 Outperform NS $7.13 -75.31% +1.82% -77.13 0 Comment
TrackJMP 86.37 12/7/2006 Outperform NS $7.15 -72.59% -5.55% -67.04 7/21/2011 @ $1.96 0 Comment
TrackUnterberg < 20 12/5/2006 Outperform NS $6.96 -8.19% -6.74% -1.45 6/24/2008 @ $6.39 0 Comment
TrackMDB < 20 10/11/2006 Outperform NS $3.92 -55.10% +6.55% -61.65 0 Comment
TrackNeedham 92.43 9/5/2006 Outperform NS $4.16 -21.88% +1.05% -22.92 3/31/2011 @ $3.25 0 Comment

Featured Broker Partners